TYME Inc Company
TYME is an emerging biotech developing cancer therapeutics intended to be broadly effective across tumor types with low toxicity profiles.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Bedminster, New Jersey, United States
Founded Date:
2011
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership